Connection
Robert MacLaren to Vasoconstrictor Agents
This is a "connection" page, showing publications Robert MacLaren has written about Vasoconstrictor Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.983 |
|
|
|
-
Obritsch MD, Bestul DJ, Jung R, Fish DN, MacLaren R. The role of vasopressin in vasodilatory septic shock. Pharmacotherapy. 2004 Aug; 24(8):1050-63.
Score: 0.226
-
Obritsch MD, Jung R, Fish DN, MacLaren R. Effects of continuous vasopressin infusion in patients with septic shock. Ann Pharmacother. 2004 Jul-Aug; 38(7-8):1117-22.
Score: 0.223
-
Stefanos SS, Kiser TH, MacLaren R, Mueller SW, Reynolds PM. Management of noncytotoxic extravasation injuries: A focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline. Pharmacotherapy. 2023 04; 43(4):321-337.
Score: 0.206
-
Murata J, Buckley M, Lehn J, Agarwal SK, Stevenson B, Martinez B, MacLaren R. Incidence of Hypotension Associated With Two Different Vasopressin Discontinuation Strategies in the Recovery Phase of Septic Shock. J Pharm Pract. 2023 Aug; 36(4):830-838.
Score: 0.192
-
Buckley MS, MacLaren R. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock. J Crit Care. 2017 12; 42:6-11.
Score: 0.138